Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia

Key facts

Sponsor

International BFM Study Group

Principal Investigator

Martin Schrappe, MD

BFM-G, Germany and Switzerland

Intervention

vincristine(drug)

Enrollment

2600 target

Eligibility

17 years · All sexes

Timeline

1995 – 2004

Study locations (8)

• Department of Pediatric Hematology-Oncology, Italian Hospital, Buenos Aires, Argentina
• Children's Cancer Research Institute, St Anna Kinderspital, Vienna, Austria
• Department of Pediatric Hemato-Oncology, Gent University Hospital, Ghent, Belgium
• Department of Pediatrics Hematology and Oncology, Hospital Roberto del Rio, Santiago, Chile
• Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czechia
• Medizinische Hochschule Hannover, Hanover, Germany
• Department of Pediatrics, Semmelweis University, Budapest, Hungary
• Pediatric Clinic - University of Milano-Bicocca, Monza, Italy

Collaborators

Associazione Italiana Ematologia Oncologia Pediatrica · BFM-A, Austria · BFM-G, Germany and Switzerland · CPH, Czech republic · European Organisation for Research and Treatment of Cancer - EORTC · Group for Acute Leukemia Treatment (GATLA). · H-POG (Hungary Pediatric Oncology Group) · PINDA, Chile

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University

See all trials for Acute lymphoblastic leukemia →